Journal of Functional Foods (Jun 2022)

Berberine combined with formononetin inhibits migration of nasopharyngeal carcinoma cells through the MAPK/ERK1/2 signaling pathway

  • Jie Liu,
  • Jingying Fan,
  • Fangliang Zhou,
  • Yu Xiong,
  • Hongjian Shi,
  • Xianwen Wang,
  • Zhenhua Zhu,
  • Yingchun He

Journal volume & issue
Vol. 93
p. 105088

Abstract

Read online

To study the effect of berberine combined with formononetin on the migration of NPC cells, and to preliminarily explore the roles of the MAPK/ERK1/2 signaling pathway.Berberine combined with formononetin synergistically inhibited the proliferation, migration and invasion of NPC cells. After treatment, the expression of EMT-related proteins N-cadherin,vimentin and MAP4K4 decreased, that of E-cadherin increased, and that of p-c-Raf, p-MEK, p-ERK1/2 was down-regulated. After MAPK/ERK 1/2 signaling pathway was activated by EGF, the inhibitory effect of berberine combined with formononetin on the key proteins p-c-Raf, p-MEK, p-ERK1/2 of MAPK/ERK1/2 signaling pathway, and the downstream proteins N-cadherin and vimentin, and the promotion of E-cadherin were weakened. Meanwhile, the activation of MAPK/ERK1/2 signaling pathway reduced the inhibitory effect of berberine combined with formononetin on the migration of NPC cells.Berberine combined with formononetin decreases the activity of the MAPK/ERK1/2 signaling pathway, thus further inhibiting the migration of NPC cells.

Keywords